Laurion Capital Management LP Karyopharm Therapeutics Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.79 - $4.59 $102,291 - $262,300	57,146 New	57,146 $102,000
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $270,497 - $646,155	-60,786 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$8.11 - $11.11 $7.46 Million - $10.2 Million	-919,678 Reduced 93.8%	60,786 $627,000
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $11.8 Million - $14.3 Million	830,712 Added 554.73%	980,464 $15.2 Million
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $2.12 Million - $2.95 Million	149,752 New	149,752 $2.19 Million
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $166,000 - $252,500	-10,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$14.38 - $27.72 $143,800 - $277,200	10,000 New	10,000 $192,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.